2019 | High-dose versus standard-dose radiation therapy for cervical esophageal cancer: Retrospective single-institution study | HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK |
2014 | High-dose Versus Standard-dose Radiotherapy with Concurrent Chemotherapy in Stages II-III Esophageal Cancer
| JAPANESE JOURNAL OF CLINICAL ONCOLOGY |
2016 | Hippocampus-Sparing Whole-Brain Radiotherapy and Simultaneous Integrated Boost for Multiple Brain Metastases From Lung Adenocarcinoma: Early Response and Dosimetric Evaluation. | TECHNOLOGY IN CANCER RESEARCH & TREATMENT |
2001 | Hyperfractionated re-irradiation using a 3-dimensional conformal technique for locally recurrent carcinoma of the nasopharynx; preliminary results
| YONSEI MEDICAL JOURNAL |
2008 | Hypofractionated high-dose intensity-modulated radiotherapy (60 Gy at 2.5 Gy per fraction) for recurrent renal cell carcinoma: A case report
| JOURNAL OF KOREAN MEDICAL SCIENCE |
2019 | Impact of Treatment-Related Lymphopenia on Immunotherapy for Advanced Non-Small Cell Lung Cancer | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS |
2016 | IMRT vs. 2D-radiotherapy or 3D-conformal radiotherapy of nasopharyngeal carcinoma : Survival outcome in a Korean multi-institutional retrospective study (KROG 11-06) | STRAHLENTHERAPIE UND ONKOLOGIE |
2012 | IMRT with simultaneous integrated boost and concurrent chemotherapy for nasopharyngeal cancer: plan evaluation and treatment outcomeoutcome
| JAPANESE JOURNAL OF CLINICAL ONCOLOGY |
2016 | Induction docetaxel and S-1 followed by concomitant radiotherapy with low-dose daily cisplatin in locally advanced head and neck carcinoma | HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK |
2020 | Intensity-Modulated Radiotherapy-Based Reirradiation for Head and Neck Cancer: A Multi-institutional Study by Korean Radiation Oncology Group (KROG 1707)
| CANCER RESEARCH AND TREATMENT |
2021 | Intracranial failure after hippocampal-avoidance prophylactic cranial irradiation in limited-stage small-cell lung cancer patients
| SCIENTIFIC REPORTS |
2012 | Is there a clinical benefit to adaptive planning during tomotherapy in patients with head and neck cancer at risk for xerostomia? | AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS |
2014 | Local control may be the key in improving treatment outcomes of esophageal squamous cell carcinoma undergoing concurrent chemoradiation. | DIGESTION |
2013 | Long-term Survival Outcomes Following Internal Mammary Node Irradiation in Stage II-III Breast Cancer: Results of a Large Retrospective Study With 12-Year Follow-up | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS |
2022 | Lymphocyte dynamics during and after chemo-radiation correlate to dose and outcome in stage III NSCLC patients undergoing maintenance immunotherapy | RADIOTHERAPY AND ONCOLOGY |
2019 | Management of Clinical T1N0M0 Esophageal Cancer
| GUT AND LIVER |
2021 | Mast cell degranulation and vascular endothelial growth factor expression in mouse skin following ionizing irradiation | JOURNAL OF RADIATION RESEARCH |
2016 | Mechanical quality assurance using light field for linear accelerators with camera calibration | PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS |
2015 | Multi-institutional analysis of T3 subtypes and adjuvant radiotherapy effects in resected T3N0 non-small cell lung cancer patients
| RADIATION ONCOLOGY JOURNAL |
2015 | Multinational Randomized Phase III Trial With or Without Consolidation Chemotherapy Using Docetaxel and Cisplatin After Concurrent Chemoradiation in Inoperable Stage III Non-Small-Cell Lung Cancer: KCSG-LU05-04 | JOURNAL OF CLINICAL ONCOLOGY |
2000 | Neoadjuvant Chemotherapy and Radiation for Inoperable cacinoma of the Maxillary Antrum: A matched-control study. | American Journal of Clinical Oncology |
2012 | Nutritional status of patients treated with radiotherapy as determined by subjective global assessment
| RADIATION ONCOLOGY JOURNAL |
2017 | Optimal Adjuvant Treatment for Curatively Resected Thoracic Esophageal Squamous Cell Carcinoma: A Radiotherapy Perspective
| CANCER RESEARCH AND TREATMENT |
2017 | Optimal dose and volume for postoperative radiotherapy in brain oligometastases from lung cancer: a retrospective study
| RADIATION ONCOLOGY JOURNAL |
2016 | Overexpression of SOX2 Is Associated with Better Overall Survival in Squamous Cell Lung Cancer Patients Treated with Adjuvant Radiotherapy
| CANCER RESEARCH AND TREATMENT |
2017 | Palliative radiation therapy in the last 30 days of life: A systematic review | RADIOTHERAPY AND ONCOLOGY |
2018 | Pancreatic radiation effect in apoptosis-related rectal radiation toxicity
| JOURNAL OF RADIATION RESEARCH |
1995 | Paraquat 중독 환자에서 전폐 방사선치료의 효과
| Journal of the Korean Society of Therapeutics Radiology(대한치료방사선과학회지) |
2006 | Patient-reported assessment of quality care at end of life: Development and validation of Quality Care Questionnaire–End of Life (QCQ–EOL) | EUROPEAN JOURNAL OF CANCER |
2013 | Patterns of care and treatment outcomes for primary thyroid lymphoma: a single institution study
| RADIATION ONCOLOGY JOURNAL |
2015 | Patterns of care for patients with nasopharyngeal carcinoma (KROG 11-06) in South Korea
| RADIATION ONCOLOGY JOURNAL |
2019 | Patterns of failures after surgical resection in olfactory neuroblastoma | JOURNAL OF NEURO-ONCOLOGY |
2019 | Patterns of local recurrence after curative resection and reconstruction for oropharyngeal and oral cancers: Implications for postoperative radiotherapy target volumes | HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK |
2012 | Patterns of regional recurrence after curative D2 resection for stage III (N3) gastric cancer: implications for postoperative radiotherapy | RADIOTHERAPY AND ONCOLOGY |
2015 | Phase II clinical and exploratory biomarker study of dacomitinib in recurrent and/or metastatic esophageal squamous cell carcinoma
| ONCOTARGET |
2012 | Phase II study of cisplatin with irinotecan as induction chemotherapy followed by chemoradiotherapy for unresectable stage III non-small cell lung cancer | ANTICANCER RESEARCH |
2007 | Phase II trial of irinotecan and cisplatin with early concurrent radiotherapy in limited-disease small-cell lung cancer
| CANCER |
2017 | Physician’s Attitude toward Treating Breakthrough Cancer Pain in Korea
| Korean Journal of Hospice and Palliative Care (한국호스피스완화의료학회지) |
2016 | PIK3CA amplification is associated with poor prognosis among patients with curatively resected esophageal squamous cell carcinoma.
| ONCOTARGET |
2009 | Positional Reproducibility and Effects of a Rectal Balloon in Prostate Cancer Radiotherapy
| JOURNAL OF KOREAN MEDICAL SCIENCE |
2021 | Postoperative Concurrent Chemoradiotherapy Versus Radiotherapy Alone for Advanced Oral Cavity Cancer in the Era of Modern Radiation Techniques
| FRONTIERS IN ONCOLOGY |
2017 | Predictive factors of symptomatic radiation pneumonitis in primary and metastatic lung tumors treated with stereotactic ablative body radiotherapy
| RADIATION ONCOLOGY JOURNAL |
2020 | Predictive value of interim 18F-FDG-PET in patients with non-small cell lung cancer treated with definitive radiation therapy
| PLOS ONE |
2006 | Predictive value of p53 and PCNA expression for occult neck metastases in patients with clinically node-negative oral tongue cancer | OTOLARYNGOLOGY-HEAD AND NECK SURGERY |
2014 | Preoperative Chemoradiotherapy Effects on Anastomotic Leakage After Rectal Cancer Resection: A Propensity Score Matching Analysis | ANNALS OF SURGERY |
2001 | Primary squamous cell carcinoma of the parotid gland | AMERICAN JOURNAL OF OTOLARYNGOLOGY |
2021 | Prognostic Significance of Interim Response Evaluation during Definitive Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma
| CANCERS |
2018 | Prognostic Significance of Sarcopenia With Inflammation in Patients With Head and Neck Cancer Who Underwent Definitive Chemoradiotherapy
| FRONTIERS IN ONCOLOGY |
2016 | Prognostic value of FDG-PET volumetric parameters in patients with p16-positive oropharyngeal squamous cell carcinoma who received curative resection followed by postoperative radiotherapy or chemoradiotherapy | HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK |
2014 | Prognostic value of neutrophil-to-lymphocyte ratio in patients treated with concurrent chemoradiotherapy for locally advanced oesophageal cancer | DIGESTIVE AND LIVER DISEASE |
2019 | Prognostic values of mid-radiotherapy 18F-FDG PET/CT in patients with esophageal cancer
| RADIATION ONCOLOGY |
2018 | Radiotherapy Versus Cordectomy in the Management of Early Glottic Cancer
| CANCER RESEARCH AND TREATMENT |
2012 | Re-irradiation of recurrent esophageal cancer after primary definitive radiotherapy
| RADIATION ONCOLOGY JOURNAL |
2018 | Re-irradiation Using Intensity-modulated Radiotherapy for Recurrent and Second Primary Head and Neck Cancer | ANTICANCER RESEARCH |
2019 | Relationship Between Sarcopenia and Prognosis in Patient With Concurrent Chemo-Radiation Therapy for Esophageal Cancer
| FRONTIERS IN ONCOLOGY |
2022 | Risk factor analysis of dental implants in patients with irradiated head and neck cancer | HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK |
2009 | Risk factors and dose-effect relationship for mandibular osteoradionecrosis in oral and oropharyngeal cancer patients | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS |
2023 | Risk of on-treatment lymphopenia is associated with treatment outcome and efficacy of consolidation immunotherapy in patients with non-small cell lung cancer treated with concurrent chemoradiotherapy | RADIOTHERAPY AND ONCOLOGY |
2015 | Role of Chemotherapy in Stage II Nasopharyngeal Carcinoma Treated with Curative Radiotherapy
| CANCER RESEARCH AND TREATMENT |
2022 | Role of postoperative radiotherapy in resected adenoid cystic carcinoma of the head and neck
| RADIATION ONCOLOGY |